youthincare: [ image is screenshot of article by ars technica with the headline stating, “is curing patients a sustainable business model?’ Goldman Sachs analysts ask/ Analyst report notes that Gilead’s hep C cure will make less than 4$ billion
tags:
original: https://hobomechanist.tumblr.com/post/173172344698